Ocular Immune Privilege and Transplantation

Frontiers in Immunology
Andrew W Taylor

Abstract

Allografts are afforded a level of protection from rejection within immune-privileged tissues. Immune-privileged tissues involve mechanisms that suppress inflammation and promote immune tolerance. There are anatomical features, soluble factors, membrane-associated proteins, and alternative antigen-presenting cells (APC) that contribute to allograft survival in the immune-privileged tissue. This review presents the current understanding of how the mechanism of ocular immune privilege promotes tolerogenic activity by APC, and T cells in response to the placement of foreign antigen within the ocular microenvironment. Discussed will be the unique anatomical, cellular, and molecular mechanisms that lessen the chance for graft destroying immune responses within the eye. As more is understood about the molecular mechanisms of ocular immune privilege greater is the potential for using these molecular mechanisms in therapies to prevent allograft rejection.

References

Jan 1, 1990·Current Eye Research·J W Streilein, S W Cousins
Oct 1, 1990·Current Eye Research·H D JampelA B Roberts
May 1, 1989·The Journal of Clinical Investigation·T B ConnorM Lansing
Jul 1, 1968·The Journal of Experimental Medicine·C F Barker, R E Billingham
May 1, 1981·The Journal of Experimental Medicine·J W Streilein, J Y Niederkorn
Nov 17, 1995·Science·T S GriffithT A Ferguson
Feb 1, 1997·The Journal of Clinical Investigation·P M StuartT A Ferguson
Feb 21, 2002·Vision Research·J Wayne StreileinParisa Zamiri
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sharmila MasliJ Wayne Streilein
May 9, 2002·Cornea·Koh-Hei Sonoda, Joan Stein-Streilein
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Douglas E Faunce, Joan Stein-Streilein
Dec 4, 2002·Ocular Immunology and Inflammation·Ling ChenAize Kijlstra
May 27, 2003·Investigative Ophthalmology & Visual Science·Andrew W Taylor, David G Yee
Jul 30, 2003·Journal of Leukocyte Biology·Jerry Y Niederkorn
Dec 12, 2003·Nature Reviews. Immunology·J Wayne Streilein
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Per A DullforceJames T Rosenbaum
Feb 25, 2005·Investigative Ophthalmology & Visual Science·Parisa ZamiriJ Wayne Streilein
Jun 21, 2005·The British Journal of Ophthalmology·T A AlbiniN A Rao
Aug 29, 2006·Investigative Ophthalmology & Visual Science·Parisa ZamiriAndrew W Taylor
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Junko HoriMiyuki Azuma
Nov 24, 2006·Investigative Ophthalmology & Visual Science·Sunao SugitaJ Wayne Streilein
Feb 1, 2007·Chemical Immunology and Allergy·Pedram Hamrah, M Reza Dana
Jul 7, 2007·Ocular Immunology and Inflammation·Andrew W TaylorJ Wayne Streilein
Jul 7, 2007·Ocular Immunology and Inflammation·Parisa ZamiriJ Wayne Streilein
Oct 27, 2007·Investigative Ophthalmology & Visual Science·Tat Fong NgAndrew W Taylor
Nov 21, 2007·Nature Neuroscience·Bahareh AjamiFabio M V Rossi
Nov 29, 2007·Nature Neuroscience·Richard M Ransohoff
May 20, 2008·Investigative Ophthalmology & Visual Science·Hiroki KanekoHiroko Terasaki

❮ Previous
Next ❯

Citations

Jun 7, 2017·American Journal of Reproductive Immunology : AJRI·Li-Ling WangAi-Hua Liao
Jun 18, 2017·Molecular Immunology·Camilla MohlinBo Nilsson
Apr 10, 2018·Ocular Immunology and Inflammation·Emmett T CunninghamManfred Zierhut
Jun 23, 2018·Stem Cells and Development·Kazuya YamashitaShigeto Shimmura
Feb 6, 2020·International Journal of Molecular Sciences·Anja WesselyMarkus Vincent Heppt
Apr 2, 2020·International Journal of Molecular Sciences·Caroline F PeddleRobert E MacLaren
Oct 1, 2020·Human Gene Therapy·Joel QuinnKanmin Xue
Oct 13, 2018·Nature Reviews. Neuroscience·John V ForresterSamantha J Dando
May 6, 2020·Nature Reviews. Microbiology·Nicholas Di PaolaGustavo Palacios
Feb 24, 2017·Cancer Metastasis Reviews·Adriana AmaroUlrich Pfeffer
Apr 30, 2019·Frontiers in Immunology·Christine I Alston, Richard D Dix
Sep 26, 2020·Frontiers in Cell and Developmental Biology·Yankai WeiHong Nian
Apr 28, 2017·Frontiers in Cellular Neuroscience·Megan B Wood, Jian Zuo
Jul 10, 2020·Bioengineering·Matthias FuestDaniela F Duarte Campos
May 29, 2018·Emerging Microbes & Infections·Mohanraj ManangeeswaranDaniela Verthelyi
Oct 26, 2018·Frontiers in Immunology·Igal Gery, Rachel R Caspi
Jun 20, 2019·International Journal of Molecular Sciences·Hassan MansoorGary Hin-Fai Yam
Jul 29, 2020·Frontiers in Immunology·Atsunobu TakedaKoh-Hei Sonoda
Mar 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wenjun XiongConstance L Cepko
Sep 11, 2019·Progress in Retinal and Eye Research·Yusuke MurakamiKoh-Hei Sonoda
Oct 14, 2019·The Journal of Allergy and Clinical Immunology·Amos GilharRalf Paus
Feb 7, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Pei-Chen LiChieh-Cheng Huang
Jan 8, 2021·Stem Cell Reviews and Reports·Sanjucta AdakBithiah Grace Jaganathan
Apr 14, 2021·Human Vaccines & Immunotherapeutics·Luca TagliaferriVincenzo Valentini
May 1, 2021·Frontiers in Immunology·Hildegund C J Ertl
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wan-Hsin ChangYuan-Hao Howard Hsu
May 22, 2021·Nature Communications·Jennifer Oyler-YanivRoy Wollman
Jul 25, 2021·International Journal of Molecular Sciences·Frida Lind-Holm MogensenMaiken Nedergaard
Aug 28, 2021·Frontiers in Immunology·Morgan Ashley HillT Konrad Rajab
Oct 3, 2020·Cell Stem Cell·Shinya Yamanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2022 Meta ULC. All rights reserved